ArticleIn vivo (Athens, Greece)

Efficacy and Safety of Tolvaptan for Patients With Autosomal Dominant Polycystic Kidney Disease in Real-world Practice: A Single Institution Retrospective Study.

Hiroshi Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.